RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
Germany
· Delayed Price · Currency is EUR 13.00
-0.30 (-2.26%)
Mar 31, 2025, 11:29 AM CET
ETR:RHK Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,596 | 1,464 | 1,446 | 1,402 | 1,360 | Upgrade
|
| Other Revenue | 273.44 | 270.75 | 215.07 | 189.2 | 185.9 | Upgrade
|
| Revenue | 1,869 | 1,735 | 1,661 | 1,591 | 1,546 | Upgrade
|
| Revenue Growth (YoY) | 7.74% | 4.43% | 4.40% | 2.92% | 4.40% | Upgrade
|
| Cost of Revenue | 1,584 | 1,532 | 1,457 | 1,409 | 1,387 | Upgrade
|
| Gross Profit | 285.07 | 202.88 | 203.78 | 182.63 | 159.02 | Upgrade
|
| Selling, General & Admin | - | 4.8 | 4.3 | 3.8 | 4 | Upgrade
|
| Other Operating Expenses | 174.3 | 93.59 | 98.63 | 80.47 | 78.25 | Upgrade
|
| Operating Expenses | 236.92 | 163.88 | 172.47 | 154.91 | 151.7 | Upgrade
|
| Operating Income | 48.15 | 39 | 31.31 | 27.72 | 7.33 | Upgrade
|
| Interest Expense | -3.44 | -3.7 | -4.1 | -3.2 | -7.4 | Upgrade
|
| Interest & Investment Income | - | 10.5 | 1.3 | 0.5 | 0.8 | Upgrade
|
| Earnings From Equity Investments | 0.11 | 0.02 | 0.08 | 0.09 | 0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.07 | 2.21 | 2.04 | 1.2 | 1.04 | Upgrade
|
| EBT Excluding Unusual Items | 55.89 | 48.03 | 30.63 | 26.31 | 1.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.55 | -0.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.3 | -0.2 | -0.1 | -1.03 | Upgrade
|
| Asset Writedown | 0.32 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 3.2 | 1.7 | 3.3 | Upgrade
|
| Pretax Income | 56.2 | 47.73 | 33.63 | 27.36 | 3.93 | Upgrade
|
| Income Tax Expense | 11 | 7.56 | 6.69 | -2.87 | 1.47 | Upgrade
|
| Earnings From Continuing Operations | 45.21 | 40.17 | 26.94 | 30.23 | 2.46 | Upgrade
|
| Minority Interest in Earnings | -1.86 | -1.46 | -1.8 | -1.93 | -1.01 | Upgrade
|
| Net Income | 43.35 | 38.71 | 25.14 | 28.3 | 1.45 | Upgrade
|
| Net Income to Common | 43.35 | 38.71 | 25.14 | 28.3 | 1.45 | Upgrade
|
| Net Income Growth | 11.98% | 53.96% | -11.14% | 1850.03% | -96.65% | Upgrade
|
| Shares Outstanding (Basic) | 67 | 67 | 67 | 67 | 67 | Upgrade
|
| Shares Outstanding (Diluted) | 67 | 67 | 67 | 67 | 67 | Upgrade
|
| Shares Change (YoY) | -0.36% | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.65 | 0.58 | 0.38 | 0.42 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.65 | 0.58 | 0.38 | 0.42 | 0.02 | Upgrade
|
| EPS Growth | 12.39% | 53.96% | -10.56% | 2000.00% | -96.91% | Upgrade
|
| Free Cash Flow | 0.57 | 46.2 | 2.1 | 19.7 | 16.3 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.69 | 0.03 | 0.29 | 0.24 | Upgrade
|
| Dividend Per Share | - | - | 0.150 | - | - | Upgrade
|
| Gross Margin | 15.25% | 11.70% | 12.27% | 11.48% | 10.29% | Upgrade
|
| Operating Margin | 2.58% | 2.25% | 1.88% | 1.74% | 0.47% | Upgrade
|
| Profit Margin | 2.32% | 2.23% | 1.51% | 1.78% | 0.09% | Upgrade
|
| Free Cash Flow Margin | 0.03% | 2.66% | 0.13% | 1.24% | 1.05% | Upgrade
|
| EBITDA | 48.78 | 101.5 | 97.61 | 94.82 | 73.73 | Upgrade
|
| EBITDA Margin | 2.61% | 5.85% | 5.88% | 5.96% | 4.77% | Upgrade
|
| D&A For EBITDA | 0.63 | 62.5 | 66.3 | 67.1 | 66.4 | Upgrade
|
| EBIT | 48.15 | 39 | 31.31 | 27.72 | 7.33 | Upgrade
|
| EBIT Margin | 2.58% | 2.25% | 1.88% | 1.74% | 0.47% | Upgrade
|
| Effective Tax Rate | 19.57% | 15.84% | 19.89% | - | 37.36% | Upgrade
|
| Revenue as Reported | 1,869 | 1,736 | 1,666 | 1,600 | 1,556 | Upgrade
|
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.